Eradication of MRSA in patients with chronic skin lesions

Not Applicable

• Conditions: L97; L89.9; U80.0; T88.9; Ulcer of lower limb, not elsewhere classified; Decubitus ulcer and pressure area, unspecified; Complication of surgical and medical care, unspecified

• Registration Number: DRKS00004597
• Lead Sponsor: niversitätsklinikum Greifswald

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-01-07
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients with chronic skin lesions, informed consent

Exclusion Criteria

chronic skin lesions colonised by other multiresistant bacteria, denial of informed consent, noncompliance, intolerance to eradication medicine, a repeated cycle of eradication according to study protocol

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of wound closure measured by medical software (Jalomed WD)

Secondary Outcome Measures

Name	Time	Method
Decolonisation rate of MRSA after 12 months, Quality of life by SF12 questionnaire after inclusion and after 6 months, economic evaluation of the additional effort by time measurement